BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12048160)

  • 1. Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes.
    Qiu ZH; Wu CT; Lao MF; Pan LZ; Li YM
    Cancer Lett; 2002 Aug; 182(2):147-54. PubMed ID: 12048160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immunogenicity in laryngeal cancer cells.
    Qiu Z; Lao M; Wu C
    Cancer Lett; 2001 Jun; 167(1):25-32. PubMed ID: 11323095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro.
    Ren SP; Wu CT; Huang WR; Lu ZZ; Jia XX; Wang L; Lao MF; Wang LS
    Cancer Immunol Immunother; 2006 Apr; 55(4):375-85. PubMed ID: 16001164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells.
    Pan D; Wei X; Liu M; Feng S; Tian X; Feng X; Zhang X
    Neurol Res; 2010 Jun; 32(5):502-9. PubMed ID: 19589203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for human nasopharyngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model.
    Ren SP; Wang L; Wang H; Wu B; Han Y; Wang LS; Wu CT
    Cancer Biother Radiopharm; 2008 Oct; 23(5):591-602. PubMed ID: 18999931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro.
    Shi M; Wang FS; Wu ZZ
    World J Gastroenterol; 2003 Jan; 9(1):73-8. PubMed ID: 12508355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.
    Feng S; Han S; Pan D; Liu M; Feng X; Dong T; Li W; Wei X
    Tumour Biol; 2014 May; 35(5):4411-7. PubMed ID: 24408016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.
    Parney IF; Petruk KC; Zhang C; Farr-Jones M; Sykes DB; Chang LJ
    Hum Gene Ther; 1997 Jun; 8(9):1073-85. PubMed ID: 9189765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adenovirus-mediated transfer of human wild-type p53, GM-CSF, and B7-1 genes efficiently produces growth suppression and apoptosis of hepatocellular cells in vitro].
    Shi M; Wang F; Liu M; Zhang B; Qiu Z; Lei Z; Masayoshi N; Gao L; Wu Z
    Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):229-31. PubMed ID: 11602056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12.
    Parney IF; Farr-Jones MA; Kane K; Chang LJ; Petruk KC
    Can J Neurol Sci; 2002 Aug; 29(3):267-75. PubMed ID: 12195617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM-CSF and B7-1 (CD80) co-stimulatory signals co-operate in the induction of effective anti-tumor immunity in syngeneic mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Hamada H; Azuma M; Asano S
    Int J Cancer; 1997 Nov; 73(4):556-61. PubMed ID: 9389572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
    Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA.
    Worgall S; Singh R; Leopold PL; Kaner RJ; Hackett NR; Topf N; Moore MA; Crystal RG
    Blood; 1999 Jan; 93(2):655-66. PubMed ID: 9885228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1.
    Büeler H; Mulligan RC
    Mol Med; 1996 Sep; 2(5):545-55. PubMed ID: 8898371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses.
    Stripecke R; Cardoso AA; Pepper KA; Skelton DC; Yu XJ; Mascarenhas L; Weinberg KI; Nadler LM; Kohn DB
    Blood; 2000 Aug; 96(4):1317-26. PubMed ID: 10942373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human brain tumor cell culture characterization after immunostimulatory gene transfer.
    Parney IF; Farr-Jones MA; Koshal A; Chang LJ; Petruk KC
    Neurosurgery; 2002 May; 50(5):1094-102. PubMed ID: 11950413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.
    Liu X; Tian PK; Ju DW; Zhang MH; Yao M; Cao XT; Gu JR
    Cancer Gene Ther; 2003 Jul; 10(7):529-39. PubMed ID: 12833133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
    Wang Q; Han D; Wang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.